Motus GI Holdings, Inc. (MOTS)

0.0810 +0.0010 (+1.25%) At close: 03:29PM EDT

Motus GI Holdings, Inc.

1301 East Broward Boulevard
3rd Floor, Suite 310
Fort Lauderdale, FL 33301
United States
954 541 8000
https://www.motusgi.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 15

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mark Pomeranz	Non-Independent Director & CEO	877.1k	N/A	1962
Ms. Ravit Ram	CFO & VP of Global Operations	371.58k	N/A	1975
Mr. Elad Amor	Chief Accounting Officer	349.87k	N/A	1984

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Corporate governance

Motus GI Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.